Gene therapy
Breakthrough in Gene Therapy: BMPER Inhibitor Offers New Hope for Pulmonary Hypertension
Researchers from the Department of Medicine at Baylor College of Medicine have made a significant discovery in the field of gene therapy. By studying the role of BMPER (bone morphogenetic protein-binding endothelial regulator) in pulmonary arterial hypertension, they have identified a potential therapeutic strategy for mitigating the disease. According to